NuCana

0 followers


ProTide technology to transform some of the most widely prescribed chemotherapy / cancer agents

Industries

Headquarters

Employees

Links

Org chart

Hugh Griffith
Founder, CEO & Board Member

Hugh Griffith

Collapse
Jeffrey Bloss
Chief Medical Officer
Don Munoz
Chief Financial Officer
Theresa Bruce
SVP, Clinical Operations
Gordon Kennovin
VP, CMC & Development
Stuart Grant
VP, Regulatory Affairs
David Harrison
Head of Translational Medicine
Adam George
Non Executive Director/audit Committee Chair
Cyrille Leperlier
Independent Director
Dr Elizabeth Ursell
Vice President, Pharmacovigilance
Neil McDonald, PhD MTOPRA
Director of Regulatory Affairs
Vanessa Smith
Clinical Supplies Manager